AMICUS THERAPEUTICS, INC. — Director's Dealing 2026

Jan 6, 2026

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AMICUS THERAPEUTICS, INC. (FOLD)
CIK: 0001178879
Period of Report: 2026-01-02

Reporting Person: Rosenberg Ellen (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2026-01-02	Common Stock	F	13426	$14.27	Disposed	494284	Direct
2026-01-03	Common Stock	F	29683	$14.27	Disposed	464601	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	15000	Indirect